Frank Clyburn's Net Worth
Frank Clyburn has an <strong>estimated net worth of $17.7 Million dollars</strong>. This is based on reported shares across multiple companies, which include INTERNATIONAL FLAVORS & FRAGRANCES INC, and Merck & Co., Inc..<br /><br />Frank Clyburn owns<strong>846 shares</strong> of INTERNATIONAL FLAVORS & FRAGRANCES INC's Common Stock which is worth $66,867.84 dollars. In the year 2022 Frank Clyburn acquired a total of <strong>1,323 shares in INTERNATIONAL FLAVORS & FRAGRANCES INC</strong>, Frank also disposed a total of <strong>477 shares of INTERNATIONAL FLAVORS & FRAGRANCES INC</strong> equalling $43.7 Thousand.<br /><br />He also owns<strong>97,095.087 shares</strong> of Merck & Co., Inc.'s Common Stock which is worth $11,579,560.08 dollars. From 2019 to 2021 Frank Clyburn acquired a total of <strong>142,103 shares in Merck & Co., Inc.</strong> at a cost of $3.33 Million, Frank also disposed a total of <strong>113,213 shares of Merck & Co., Inc.</strong> equalling $9.3 Million.
Estimate Recalculated Jul 5, 2024 03:12PM EST
Who is Frank Clyburn?
SEC CIK
Frank Clyburn's CIK is 0001763963
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DuPont de Nemours, Inc. (DD) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +37.87% | 2.21K |
$77.05 | $170,049.35 | 8.03K |
Apr 28
| |||
Form 4
| +150.83% | 3.44K |
$49.46 | $170,043.48 | 5.72K |
May 27
| |||
Form 4
|
∞
| 2.24K |
$76.10 | $170,464.00 | 2.24K |
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +118.32% | 1K |
$75.88 | -$24,509.24 | 1.85K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
∞
| 846 |
$91.64 | -$43,712.28 | 846 |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Merck & Co., Inc. (MRK) No price found
EVP & Pres ? Human Health
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
| +1.25% | 1.2K |
$87.96 | -$3,388,571.19 | 97.1K |
Oct 30 - Nov 1
| |||
Form 4
|
—
|
0
|
$78.32 | -$1,513,440.22 | 94.35K |
May 10
| |||
Form 4
| +1.04% | 967 |
$75.98 | $73,472.66 | 94.35K |
May 4
| |||
Form 4
| +11.34% | 9.43K |
$72.62 | $684,951.84 | 92.59K |
Feb 26
| |||
Form 4
| +1.41% | 1.15K |
$75.89 | $87,273.50 | 82.52K |
Oct 30
| |||
Form 4
|
—
|
0
|
$81.55 | -$1,539,273.62 | 80.76K |
Aug 5
| |||
Form 4
| +3.68% | 2.87K |
$77.13 | $221,370.66 | 80.76K |
May 4 - May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +6.78% | 4.91K |
$76.56 | $375,526.80 | 77.3K |
Feb 28
| |||
Form 4
| +1.64% | 1.16K |
$85.10 | -$95,907.70 | 71.9K |
Oct 30
| |||
Form 4
| +3.29% | 2.23K |
$78.33 | -$169,349.46 | 69.83K |
May 10
| |||
Form 4
|
—
|
0
|
$58.51 | -$960,932.50 | 67.6K |
May 7
| |||
Form 4
| +1.45% | 966 |
$80.00 | -$75,040.00 | 67.6K |
May 3 - May 4
| |||
Form 4
| +6.46% | 4.02K |
$80.38 | $322,886.46 | 66.19K |
Feb 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||